Colgate-Palmolive Company

(New York Stock Exchange)
Somewhat Bullish +45

Hedge Funds Think Colgate-Palmolive Is One of the Best Dividend King Stocks To Buy

πŸ“ˆ Colgate-Palmolive has increased its dividend for 63 consecutive years, earning its status as a 'Dividend King' with an uninterrupted payment history dating back to 1895.

🦷 The company maintains a dominant 41.3% market share in the toothpaste sector and holds a significant position in the manual toothbrush market.

🐾 Hill's Science Diet is a key growth asset within the Pet Nutrition segment, catering to pet owners willing to pay premium prices for health-focused nutrition.

πŸ’° In September 2026, the company declared a quarterly dividend of $0.53 per share, providing an annual yield of approximately 2.5% at a stock price of $86.

πŸ“‰ Operating cash flow reached $1.742 billion in the first six months of 2026, demonstrating sufficient liquidity to support regular dividend payments and business reinvestment.

βš–οΈ The earnings payout ratio is currently around 84%, meaning a large portion of reported profits are paid out as dividends rather than retained for expansion.

πŸ“Š Colgate-Palmolive trades at a forward P/E multiple of approximately 21x, reflecting a premium valuation for its mature consumer goods business and stable cash flows.

πŸ† Hedge funds rank CL among the top 10 'Dividend King' stocks, though it trails nine other companies on the specific list mentioned in the analysis.

πŸ“‰ Compared to Procter & Gamble (PG), Colgate is viewed as a cheaper investment with similar forward P/E multiples but expected faster earnings growth.

⚠️ The high valuation implies an earnings yield of about 4.8%, which may be less attractive than government bonds if interest rates remain elevated or stable.

Bullish Signals
  • Colgate-Palmolive has a proven track record of increasing dividends for 63 consecutive years, establishing it as a reliable 'Dividend King' with an uninterrupted payment history since 1895.
  • The company holds a dominant 41.3% market share in the toothpaste market and maintains strong brand recognition that creates high barriers to entry for competitors.
  • Hill's Science Diet is a highly profitable asset within the Pet Nutrition segment, benefiting from consumers' willingness to pay premium prices for veterinary-recommended pet food.
  • Operating cash flow of $1.742 billion in the first half of 2026 provides management with ample scope to sustain dividend payments and fund business reinvestment initiatives.
  • Hedge funds consider CL one of the top 10 'Dividend King' stocks, validating its status as a premier defensive investment for long-term portfolios.
Risk Factors
  • The stock trades at a premium valuation with a forward P/E of approximately 21x, leaving little room for earnings to decline without significantly impacting the share price.
  • With a forward P/E of 21x and an implied earnings yield of 4.8%, the stock may be less attractive than government bonds for investors seeking competitive returns in a stable rate environment.
  • The current dividend yield of approximately 2.5% is considered conservative and insufficient for investors requiring substantial immediate income compared to higher-yielding alternatives.
Full Analysis
Colgate-Palmolive (NYSE:CL) is highlighted as a top-tier 'Dividend King' stock, having increased its dividend for 63 consecutive years since 1962. The company maintains dominant market positions in oral care and pet nutrition, holding a 41.3% share of the toothpaste market and a strong presence in the Hill's Science Diet brand. Its business model relies on essential consumer habits that provide stable revenue streams regardless of economic conditions. In September 2026, Colgate announced a quarterly dividend of $0.53 per share, resulting in an annual yield of approximately 2.5% at a share price of $86. While the company generated robust operating cash flow of $1.742 billion in the first half of 2026, its earnings payout ratio stands at roughly 84%, indicating that a significant portion of reported profits is distributed to shareholders rather than reinvested. Investors view CL as a defensive play for consistency rather than high current income, though the stock trades at a premium with a forward P/E of 21x. Analysts note that while the company offers reliable growth and brand strength, its valuation leaves little room for earnings declines. The article suggests CL is a solid choice for long-term portfolios prioritizing dividend safety over immediate yield or high-growth potential.